What is the Wegovy Pill?

DoktorABC editorial team

Accurate, up-to-date health information written by our editorial team and reviewed by UK-registered prescribers.

How does the Wegovy Pill work?

The Wegovy Pill works by mimicking the action of GLP-1, a naturally occurring hormone released by the body after eating. It acts on areas of the brain that regulate appetite, helping people feel fuller for longer, reducing hunger, and decreasing food cravings.

What makes the tablet formulation distinct from the injection is how semaglutide enters the body. The pill contains an absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate), which temporarily raises the pH around the tablet in the stomach, allowing a portion of the semaglutide to pass through the stomach lining and into the bloodstream. This is why the strict fasting and water-only rules are essential: food, other drinks, and other medicines all reduce this absorption process, sometimes significantly.

In practical terms, most people notice a reduction in appetite throughout the day, feel satisfied after smaller meals, and find cravings easier to manage. Like the injection, the Wegovy Pill works best alongside a reduced-calorie diet and increased physical activity rather than as a standalone solution.

What is in the Wegovy Pill?

The active ingredient is semaglutide (oral). It is manufactured by Novo Nordisk and is a prescription-only medicine in the UK. It is the same active ingredient as the weekly Wegovy injection but formulated as a tablet using an absorption enhancer that allows semaglutide to cross the stomach lining.

How effective is the Wegovy Pill?

Clinical trial data shows the Wegovy Pill produces meaningful weight loss for most people who take it correctly alongside diet and lifestyle changes.

The evidence comes from the OASIS 4 trial, a 64-week randomised controlled study in adults with obesity or overweight with at least one weight-related health condition. Participants taking the 25 mg tablet lost an average of approximately 13.6% of their body weight compared to 2.4% on placebo. Among those who adhered fully to treatment throughout the trial, average weight loss reached approximately 16.6%.

To put that in practical terms: someone starting at 100 kg could expect to lose approximately 14-17 kg over 64 weeks, alongside meaningful dietary and lifestyle changes. These are averages; individual results vary.

How does the Wegovy Pill compare to other treatments?

The 25 mg tablet produces broadly similar results to the weekly 2.4 mg Wegovy injection. The higher 7.2 mg injection dose, approved in January 2026, produces greater average weight loss than the tablet at its current maximum. Mounjaro (tirzepatide) produces average weight loss of up to approximately 21% at 15 mg. These figures come from separate trials rather than direct comparisons, so they should be read as context rather than a precise ranking.

Wegovy Pill vs Wegovy injection: What is the difference?

Both contain semaglutide and work through the same mechanism. The key practical differences are:

At matched doses, weight loss outcomes are broadly similar. The Wegovy injection can be titrated to a higher dose (7.2 mg) that is not currently available with the tablet, producing greater average weight loss in some patients. Neither is objectively better; the right choice depends on individual preference, lifestyle, and clinical assessment. For a more in depth comparison, see our guide on Wegovy pills vs. Wegovy injection. 

Who can take Wegovy Pill?

The Wegovy Pill may be prescribed to adults with a BMI of 30 or above, or those who are overweight with a BMI between 27 and 30 with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity.

Patients already established on the Wegovy injection who are interested in switching to the tablet form should speak to their prescriber, who can assess whether a transition is appropriate based on their individual treatment history and current dose. 

Suitability is always determined by a prescriber following a clinical assessment. This is not a simple tick-box process: it takes into account your full medical history, current treatments, and treatment goals.

How do you take the Wegovy Pill?

The administration rules are strict and directly affect how much semaglutide your body absorbs. Food, other drinks, and other medicines significantly reduce absorption through the stomach lining. Following the instructions precisely is not optional.

• Take one tablet first thing in the morning, immediately after waking
• Take on an empty stomach (no food for at least eight hours)
• Swallow whole with a small sip of plain water only (no more than 120 ml)
• Wait at least 30 minutes before eating, drinking anything else, or taking other medicines
• Do not split, crush, or chew the tablet

What are the Wegovy Pill doses?

The starting dose is 1.5 mg once daily, increasing to 4 mg, 9 mg, and 25 mg, with a minimum of one month at each dose level before stepping up. 25 mg is the maximum dose, not a target. Some people achieve adequate results at an earlier step and may be advised to remain there.Your titration schedule will be set and adjusted by your prescriber.

What are the side effects of Wegovy Pill?

The most common side effects are gastrointestinal, including nausea, diarrhoea, constipation, and vomiting. These are usually most pronounced when starting or stepping up in dose and typically improve as the body adjusts. Staying well hydrated is particularly important if vomiting or diarrhoea occurs.

Other common effects include stomach discomfort, indigestion, bloating, reduced appetite, tiredness, dizziness, and headache.

How much does the Wegovy Pill cost and how do you get it in the UK?

The MHRA approved the Wegovy Pill on 11 June 2026, and it will be available in the UK on private prescription as of July 2026. It is not currently available on the NHS. NHS access requires a separate cost-effectiveness evaluation by NICE, which typically takes 6-12 months following MHRA approval, and patients should not expect NHS availability in 2026.

The Wegovy Pill requires a private prescription following a clinical consultation. DoktorABC connects UK patients with licensed prescribers who can assess suitability and issue private prescriptions where clinically appropriate. Visit the DoktorABC Wegovy Pill page for current pricing and to begin a consultation when available.

Is Wegovy Pill the same as Rybelsus?

No. Both Wegovy Pill and Rybelsus contain oral semaglutide, but they are different products with different licensed indications. Rybelsus is available at 3 mg, 7 mg, and 14 mg and is licensed for type 2 diabetes management. The Wegovy Pill at 25 mg is licensed specifically for weight management in adults with overweight or obesity. They are not interchangeable.

Final thoughts

The Wegovy Pill represents a meaningful development in weight management: the UK's first licensed oral GLP-1 treatment, offering an injection-free alternative with broadly comparable efficacy to the standard 2.4 mg weekly injection. For people who are needle-averse or find the logistics of injectable treatment inconvenient, it opens a new and clinically credible pathway.

As with all weight management medicines, it works best as part of a broader commitment to dietary change and increased activity, not as a replacement for it. Eligibility and suitability are always determined by a prescriber.

FAQ

The DoktorABC medical advisory board

Dr. Roland Ruiken

Medical advisor, Norway

Dr. Viktor Simunovic

Medical advisor, Croatia

To the medical advisory board